| Issue Date | Title | Author(s) |
| 2012-10-01 | Pharmacovigilance in hospice/palliative care: Rapid report of net clinical effect of metoclopramide | Currow, DC; Vella-Brincat, J; Fazekas, B; Clark, K; Doogue, M; Rowett, D |
| 2016-09-01 | Pharmacovigilance in hospice/palliative care: Net effect of pregabalin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
| 2015-01-01 | Analysis of drug interactions at the end of life | Morgan, NA; Rowett, D; Currow, DC |
| 2015-01-01 | Pharmacovigilance in hospice/palliative care: Net effect of gabapentin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
| 2012-03-01 | An international initiative to create a collaborative for pharmacovigilance in hospice and palliative care clinical practice | Currow, DC; Rowett, D; Doogue, M; To, THM; Abernethy, AP |
| 2014-01-01 | Pro re nata prescribing in a population receiving palliative care: A prospective consecutive case note review | Russell, BJ; Rowett, D; Currow, DC |
| 2013-03-01 | Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisation | Clark, K; Rowett, D; Robinson, M; Currow, DC |
| 2013-03-01 | Chronic refractory dyspnoea: Evidence based management | Wiseman, R; Rowett, D; Allcroft, P; Abernethy, A; Currow, D |
| 2013-11-01 | Pharmacovigilance in hospice/palliative care: Net effect of haloperidol for delirium | Crawford, GB; Meera Agar, M; Quinn, SJ; Phillips, J; Litster, C; Michael, N; Doogue, M; Rowett, D; Currow, DC |
| 2017-10-01 | The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care | To, THM; LeBlanc, TW; Eastman, P; Neoh, K; Agar, MR; To, LB; Rowett, D; Vandersman, Z; Currow, DC |
